MedTrace Logo

Efficacy of External Application of Rosemary Oil in Patients With Chemotherapy-Induced Peripheral Neuropathy: a Feasibility Study

NCT05855044 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2025-06-04

No results posted yet for this study

Summary

Chemotherapy can cause sensory disorders in the hands and feet called peripheral neuropathy. Typical symptoms are pain, loss of sensation, tingling, numbness, and gait disturbances, which worsen patients' quality of life and increase the risk of falls. Little is known about the effect of rosemary oil (applied to hands and feet) on the symptoms of neuropathy. The present study is a feasibility study to see if it is possible to conduct a clinical trial in patients diagnosed with cancer and receiving chemotherapy who report peripheral neuropathy and apply rosemary oil to their hands and feet.

Conditions

  • Chemotherapy-induced Peripheral Neuropathy (CIPN)

Interventions

OTHER

Rosemary oil application

Application of Rosemary oil (10%) to both hands and both feet once a day for 24 weeks

Sponsors & Collaborators

  • ARCIM Institute Academic Research in Complementary and Integrative Medicine

    lead OTHER

Principal Investigators

  • Jan Vagedes, Dr. · ARCIM Institute Academic Research in Complementary and Integrative Medicine

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-01-18
Primary Completion
2025-06-03
Completion
2025-06-03

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05855044 on ClinicalTrials.gov